GTC Biotherapeutics (fka GTCB)

[ghmm]

Interesting questions about Biosimilars on Genzyme call, about 22 minutes into the call (and then a followup about 29:30 in). It was a spoon fed question but Henri Termeer and Alison Lawton seemed to indicate that the hurdle could be higher for approval of biosimilars with the FDA being much more conservative.

#msg-28670925